Australia markets open in 1 hour 3 minutes

Cellectis S.A. (CLLS)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
3.0600-0.1800 (-5.56%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 219.91M
Enterprise value 101.15M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)231.07
Price/book (mrq)2.60
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 373.86%
S&P500 52-week change 326.27%
52-week high 33.7740
52-week low 30.9630
50-day moving average 32.6566
200-day moving average 32.4242

Share statistics

Avg vol (3-month) 354.81k
Avg vol (10-day) 3125.93k
Shares outstanding 571.96M
Implied shares outstanding 672.54M
Float 839.03M
% held by insiders 19.40%
% held by institutions 114.66%
Shares short (30 Apr 2024) 4672.77k
Short ratio (30 Apr 2024) 416.25
Short % of float (30 Apr 2024) 4N/A
Short % of shares outstanding (30 Apr 2024) 40.91%
Shares short (prior month 28 Mar 2024) 4676.48k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,486.33%

Management effectiveness

Return on assets (ttm)-20.42%
Return on equity (ttm)-110.93%

Income statement

Revenue (ttm)9.19M
Revenue per share (ttm)0.16
Quarterly revenue growth (yoy)-88.50%
Gross profit (ttm)N/A
EBITDA -78.78M
Net income avi to common (ttm)-109.45M
Diluted EPS (ttm)-1.9200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)203.82M
Total cash per share (mrq)3.12
Total debt (mrq)105.86M
Total debt/equity (mrq)124.99%
Current ratio (mrq)1.50
Book value per share (mrq)1.30

Cash flow statement

Operating cash flow (ttm)-24.75M
Levered free cash flow (ttm)-19.84M